Skip to main content
logo
Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
131.65
+0.81 (0.62%)
At close: May 1, 2026, 4:00 PM EDT
131.83
+0.18 (0.14%)
After-hours: May 1, 2026, 7:55 PM EDT

Gilead Sciences Product Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
HIV
20.75B20.40B20.20B19.86B19.61B18.85B18.45B18.33B
HIV Growth
5.82%8.23%9.50%8.34%7.90%3.28%2.06%3.68%
Oncology
3.24B3.24B3.27B3.26B3.29B3.21B3.16B3.05B
Oncology Growth
-1.61%0.81%3.19%6.75%12.18%15.46%22.16%27.71%
Liver Disease
3.22B3.09B3.01B3.04B3.02B2.99B2.97B2.85B
Liver Disease Growth
6.45%3.27%1.31%6.92%8.55%7.43%3.42%0.21%
Veklury
912.00M1.04B1.45B1.55B1.80B2.18B2.13B2.17B
Veklury Growth
-49.28%-52.45%-31.67%-28.70%-17.71%-11.52%-22.84%-26.37%
Other
800.00M779.00M796.00M874.00M889.00M906.00M921.00M884.00M
Other Growth
-10.01%-14.02%-13.57%-1.13%3.49%-0.44%3.02%-2.54%

Revenue by Type

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Product
28.92B28.55B28.72B28.58B28.61B28.14B27.62B27.28B
Product Growth
1.07%1.44%3.96%4.77%6.22%3.48%1.63%1.94%
Other
527.00M538.00M144.00M158.00M143.00M155.00M181.00M175.00M
Other Growth
268.53%247.10%-20.44%-9.71%-21.43%-19.69%-9.95%-39.24%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.